ResArgin for Weight Loss

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: Dr. Heather Hausenblaus

Disqualifiers: Diabetes, Seizures, Musculoskeletal issues, others

Compensation: Varies

Number of Visits: 30

Duration: 12 weeks

60 Participants Needed

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to learn if the supplement ResArgin (a reservatrol-based supplement) works to slow down muscle loss during a period of fat loss. Other related health outcomes such as sleep, mood, and activity will be assessed. The main questions it aims to answer are: Does ResArgin improve muscle loss? Does ResArgin improve sleep quality, activity, mood, and body satisfaction. Researchers will compare ResArgin to a placebo (a look-alike substance that contains no active ingredients) to see if ResArgin works to improve muscle loss and related health outcomes. Participants will: Take ResArgin or the Placebo every day for 3 months Assessment will occur at Baseline, Day 30, Day 60, and Day 90. Participants will complete a daily diary of their mood and health.

Eligibility Criteria

This trial is for adults looking to lose weight without losing muscle. Participants must be willing to take a daily supplement (ResArgin or placebo) and keep a diary of their mood and health for 3 months. Specific inclusion and exclusion criteria are not provided, but typically involve age, health status, and commitment to the study protocol.

Inclusion Criteria

I am between 25 and 60 years old.

I am slightly to moderately overweight.

Exclusion Criteria

Metabolic disorder

I have a sleep disorder.

Psychiatric condition

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants take ResArgin or the placebo daily for 3 months to assess muscle loss and related health outcomes

12 weeks

Assessments at Baseline, Day 30, Day 60, and Day 90

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• ResArgin

Trial Overview The trial tests if ResArgin can help maintain muscle during weight loss compared to a placebo. It also examines whether ResArgin affects sleep quality, activity levels, mood, and body satisfaction over three monthly assessments.

Participant Groups

Group I: ResArgin Active Control 1 Intervention

A resveratrol-based supplement. Participants will receive a daily oral dose of ResArgin containing \[50 mg/d\] of trans-Resveratrol for 90 days.

Group II: placebo Placebo Group 1 Intervention

Placebo consists of oat hull. Participants receive a daily oral dose of a placebo matching the appearance and dosage form of ResArgin for 90 days.

Who Is Running the Clinical Trial?

Dr. Heather Hausenblaus

Lead Sponsor

Trials

1

Recruited

60+